Skip to main content
. 2020 Sep 1;137(10):1377–1391. doi: 10.1182/blood.2020007897

Figure 2.

Figure 2.

RUNX1 mutations in pDC-AML. (A) Oncoplot of mutations in pDC-AML. (B) Lollipop graph of RUNX1 mutations in pDC-AML. (C) VAF of the major mutations compared with blast percentages. AML, NOS, AML not otherwise specified; AML-MRC, AML with myelodysplasia-related changes; t-AML: therapy-related AML.